| Methods |
Blinding of randomisation: yes
Blinding of intervention: can't tell but probably impossible
Complete follow‐up: yes
Blinding of outcome measurement: can't tell |
| Participants |
Term infants, >2500g, >24 hours of age.
Infant with haemolytic disease, sepsis, respiratory distress, direct SBR >2% or unable to be breast fed during study period excluded.
Qualifying SBR >205.
Fibreoptic n=17, conventional n=17. |
| Interventions |
Fibreoptic: BiliBlanket at 42.6 microwatts/cm2/nm (measured).
Conventional: 5 Daylight and 2 Blue "Interelectric Biliblue" F20T12" BBY (General Electric) at 9.8 microwatts/cm2/nm (measured). |
| Outcomes |
% reduction in SBR at 8, 16, 24, 32, 40 and 48 hours.
Duration of phototherapy. |
| Notes |
Data complete |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment? |
Low risk |
A ‐ Adequate |
